Nabriva acquires Zavante

Nabriva Therapeutics plc (NASDAQ:NBRV) acquired Zavante Therapeutics Inc. (San Diego, Calif.) for 8.2 million Nabriva shares, or $27.1 million based

Read the full 205 word article

User Sign In